Evidence map›Paper›PMID 33132158›Full record

ArticleBiochimie2021

SNAIL Transctiption factor in prostate cancer cells promotes neurite outgrowth.

Gabrielle Edwards, Taaliah Campbell, Veronica Henderson, Alira Danaher, Daqing Wu, Rekha Srinivasan, Khosrow Rezvani, Valerie A Odero-Marah

Open access · greenAbstract read
In one paragraph

Article in Biochimie, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Mesenchymal stroma drives axonogenesis and nerve-induced aggressiveness in osteosarcoma.Journal of experimental & clinical cancer research : CR · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Gabrielle EdwardsCenter for Cancer Research and Therapeutic Development, Department of Biological Sciences, Clark Atlanta University, Atlanta, GA, 30314, United States.
Taaliah CampbellCenter for Cancer Research and Therapeutic Development, Department of Biological Sciences, Clark Atlanta University, Atlanta, GA, 30314, United States.
Veronica HendersonCenter for Cancer Research and Therapeutic Development, Department of Biological Sciences, Clark Atlanta University, Atlanta, GA, 30314, United States.
Alira DanaherCenter for Cancer Research and Therapeutic Development, Department of Biological Sciences, Clark Atlanta University, Atlanta, GA, 30314, United States.
Daqing WuCenter for Cancer Research and Therapeutic Development, Department of Biological Sciences, Clark Atlanta University, Atlanta, GA, 30314, United States.
Rekha SrinivasanDivision of Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD, 57069, United States.
Khosrow RezvaniDivision of Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD, 57069, United States.
Valerie A Odero-MarahCenter for Cancer Research and Therapeutic Development, Department of Biological Sciences, Clark Atlanta University, Atlanta, GA, 30314, United States. Electronic address: vodero-marah@cau.edu.
Center for Cancer Research · USUniversity of South Dakota · US

Funding

Tracking and Evaluation CoreU54GM128729 · NIGMS · UNIVERSITY OF NORTH DAKOTA · PI SCHWARTZ, GARY G · 2018 to 2022
$20.3M
To Investigate Molecular Mechanisms of Aging-Related Growth of the Prostate - Implications in Prostate Tumorigenesis and Cancer TreatmentU54MD007590 · NIMHD · CLARK ATLANTA UNIVERSITY · PI Mustapha Alhassan · 2019 to 2026
$17.1M
Research Initiative for Scientific Enhancement (RISE)R25GM060414 · NIGMS · CLARK ATLANTA UNIVERSITY · PI MUSEY, PAUL I. · 1999 to 2020
$13.7M
NIGMS NIH HHS R25 GM060414NIGMS NIH HHS U54 GM128729NIMHD NIH HHS U54 MD007590
6 · The paper itself

Abstract

Neurite outgrowth involves reciprocal signaling interactions between tumor cells and nerves where invading tumor cells have acquired the ability to respond to pro-invasive signals within the nerve environment. Neurite outgrowth could serve as a mechanism leading to invasion of cancer cells into the nerve sheath and subsequent metastasis. Snail transcription factor can promote migration and invasion of prostate cancer cells. We hypothesized that prostate cancer cell interaction with nerve cells will be mediated by Snail expression within prostate cancer cells. For this study we utilized various prostate cancer cell lines: C4-2 non-silencing (NS, control); C4-2 Snail shRNA, (stable Snail knockdown); LNCaP Neo (empty vector control) and LNCaP Snail (stably over-expressing Snail). Cancer cell adhesion and migration towards nerve cells (snF96.2 or NS20Y) was examined by co-culture assays. Conditioned media (CM) collected from C4-2 cells was cultured with nerve cells (PC-12 or NS20Y) for 48 h followed by qualitative or quantitative neurite outgrowth assay. Our results showed that cancer cells expressing high levels of Snail (LNCaP Snail/C4-2 NS) displayed significantly higher migration adherence to nerve cells, compared to cells with lower levels of Snail (LNCaP Neo/C4-2 Snail shRNA). Additionally, LNCaP Snail or C4-2 NS (Snail-high) CM led to a higher neurite outgrowth compared to the LNCaP Neo or C4-2 Snail shRNA (Snail-low). In conclusion, Snail promotes migration and adhesion to nerve cells, as well as neurite outgrowth via secretion of soluble factors. Therefore, targeting cancer cell interaction with nerves may contribute to halting prostate cancer progression/metastasis.

Indexed as

AnimalsCell AdhesionCell CommunicationCell LineCell MovementCell ProliferationGene SilencingHumansMaleMiceNeuronal OutgrowthNeuronsProstatic NeoplasmsRatsSnail Family Transcription FactorsSNAI1 protein, humanSnail Family Transcription FactorsCancer cellNerveNeuriteNeurite outgrowthProstate cancerSnail

Identifiers

PMID33132158
PMCPMC8253511
OpenAlexW3094112351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.